Colonization dynamics of extended-spectrum beta-lactamase-producing Enterobacterales in the gut of Malawian adults.


Journal

Nature microbiology
ISSN: 2058-5276
Titre abrégé: Nat Microbiol
Pays: England
ID NLM: 101674869

Informations de publication

Date de publication:
10 2022
Historique:
received: 11 10 2021
accepted: 25 07 2022
pubmed: 7 9 2022
medline: 1 10 2022
entrez: 6 9 2022
Statut: ppublish

Résumé

Drug-resistant bacteria of the order Enterobacterales which produce extended-spectrum beta-lactamase enzymes (ESBL-Enterobacterales, ESBL-E) are global priority pathogens. Antimicrobial stewardship interventions proposed to curb their spread include shorter courses of antimicrobials to reduce selection pressure but individual-level acquisition and selection dynamics are poorly understood. We sampled stool of 425 adults (aged 16-76 years) in Blantyre, Malawi, over 6 months and used multistate modelling and whole-genome sequencing to understand colonization dynamics of ESBL-E. Models suggest a prolonged effect of antimicrobials such that truncating an antimicrobial course at 2 days has a limited effect in reducing colonization. Genomic analysis shows largely indistinguishable diversity of healthcare-associated and community-acquired isolates, hence some apparent acquisition of ESBL-E during hospitalization may instead represent selection from a patient's microbiota by antimicrobial exposure. Our approach could help guide stewardship protocols; interventions that aim to review and truncate courses of unneeded antimicrobials may be of limited use in preventing ESBL-E colonization.

Identifiants

pubmed: 36065064
doi: 10.1038/s41564-022-01216-7
pii: 10.1038/s41564-022-01216-7
pmc: PMC9519460
mid: EMS151721
doi:

Substances chimiques

Anti-Bacterial Agents 0
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1593-1604

Subventions

Organisme : Wellcome Trust
ID : 217303
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206545
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 109105
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206194
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

J Infect Dis. 2018 Jan 30;217(4):628-636
pubmed: 29186529
Microb Genom. 2016 Apr 29;2(4):e000056
pubmed: 28348851
Clin Infect Dis. 2017 Jul 15;65(2):208-215
pubmed: 28369261
Clin Infect Dis. 2020 Nov 5;71(8):1847-1855
pubmed: 31688916
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Genome Res. 2015 Jul;25(7):1043-55
pubmed: 25977477
Lancet Infect Dis. 2017 Oct;17(10):1042-1052
pubmed: 28818544
Clin Infect Dis. 2015 Aug 1;61(3):305-12
pubmed: 25888672
Bioinformatics. 2006 Jul 1;22(13):1658-9
pubmed: 16731699
J Antimicrob Chemother. 2017 Jun 1;72(6):1602-1609
pubmed: 28333330
Clin Infect Dis. 2018 Jul 2;67(2):161-170
pubmed: 29340588
Infect Drug Resist. 2020 Jul 22;13:2521-2535
pubmed: 32801790
J Antimicrob Chemother. 2019 May 1;74(5):1223-1232
pubmed: 30778540
Genome Med. 2014 Nov 20;6(11):90
pubmed: 25422674
Clin Infect Dis. 2022 May 30;74(10):1840-1849
pubmed: 34407175
J Clin Microbiol. 2015 Jul;53(7):2122-31
pubmed: 25903575
S Afr Med J. 2015 Apr 06;105(5):325
pubmed: 26242647
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Microb Genom. 2016 Aug 25;2(8):e000083
pubmed: 28348874
Genome Res. 2019 Feb;29(2):304-316
pubmed: 30679308
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Proc Biol Sci. 2018 Jun 13;285(1880):
pubmed: 29899074
Wellcome Open Res. 2019 Oct 23;4:160
pubmed: 31976380
Genome Med. 2017 Jul 25;9(1):70
pubmed: 28738847
Microb Genom. 2023 Jun;9(6):
pubmed: 37314322
Clin Infect Dis. 2018 Apr 17;66(9):1368-1376
pubmed: 29149242
J Hosp Med. 2018 Jan 25;13(5):336-342
pubmed: 29370318
BMC Genomics. 2018 Dec 4;19(1):870
pubmed: 30514209
Clin Infect Dis. 2020 Dec 3;71(9):e478-e486
pubmed: 32060523
Lancet Microbe. 2021 Apr;2(4):e151-e158
pubmed: 33821248
J Clin Microbiol. 2005 Aug;43(8):4178-82
pubmed: 16081970
Sci Transl Med. 2017 Nov 22;9(417):
pubmed: 29167391
Genome Biol. 2014 Mar 03;15(3):R46
pubmed: 24580807
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Antimicrob Agents Chemother. 2014 Jul;58(7):3895-903
pubmed: 24777092
BMC Med. 2018 Aug 23;16(1):137
pubmed: 30134939
Lancet Infect Dis. 2017 Jan;17(1):78-85
pubmed: 27751772
J Stat Softw. 2017;76:
pubmed: 36568334
Mol Microbiol. 2006 Jun;60(5):1136-51
pubmed: 16689791
Stat Med. 1995 Sep 30;14(18):1975-83
pubmed: 8677398
Microb Genom. 2016 Nov 30;2(11):e000094
pubmed: 28348834
Lancet Microbe. 2021 Nov;2(11):e575-e583
pubmed: 35544081
PLoS One. 2018 Mar 21;13(3):e0193834
pubmed: 29561861
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Microb Genom. 2017 Sep 4;3(10):e000131
pubmed: 29177089
Microb Genom. 2022 Mar;8(3):
pubmed: 35302438
Elife. 2019 Dec 03;8:
pubmed: 31793878
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Mol Biol Evol. 2014 Jul;31(7):1929-36
pubmed: 24739305
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D32-6
pubmed: 16381877
J Antimicrob Chemother. 2020 Mar 1;75(3):492-507
pubmed: 31742611
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349

Auteurs

Joseph M Lewis (JM)

Malawi-Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi. jmlewis@liverpool.ac.uk.
Liverpool School of Tropical Medicine, Liverpool, UK. jmlewis@liverpool.ac.uk.
University of Liverpool, Liverpool, UK. jmlewis@liverpool.ac.uk.
Wellcome Sanger Institute, Hinxton, UK. jmlewis@liverpool.ac.uk.

Madalitso Mphasa (M)

Malawi-Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi.

Rachel Banda (R)

Malawi-Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi.

Mathew A Beale (MA)

Wellcome Sanger Institute, Hinxton, UK.

Eva Heinz (E)

Liverpool School of Tropical Medicine, Liverpool, UK.

Jane Mallewa (J)

Kamuzu University of Health Sciences, Blantyre, Malawi.

Christopher Jewell (C)

University of Lancaster, Lancaster, UK.

Brian Faragher (B)

Liverpool School of Tropical Medicine, Liverpool, UK.

Nicholas R Thomson (NR)

Wellcome Sanger Institute, Hinxton, UK.
London School of Hygiene and Tropical Medicine, London, UK.

Nicholas A Feasey (NA)

Malawi-Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi.
Liverpool School of Tropical Medicine, Liverpool, UK.
London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH